Search clinical trials for: Immunological analysis:

Total 39336 results

Leeds Cancer Centre at St. James's University Hospital

Unknown

Studying Tumor Tissue Samples From Patients With Melanoma Who Have Undergone Sentinel Lymph Node Biopsy

Melanoma (Skin)

United Kingdom
Fondazione Don Carlo Gnocchi Onlus
Istituto Auxologico Italiano

Recruiting

Salivary Biomarker Discovery by Raman Spectroscopy in ALS (SalivALS) (SalivALS)

Amyotrophic Lateral Sclerosis

Italy
Ziv Hospital

Unknown

Characterization of Microbial, Immune and Epigenetic Biomarkers for Major Depressive Disorder and ECT Treatment

Major Depressive Disorder
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Biomarkers in Tissue and Blood Samples From Patients With Early-Stage Non-Small Cell Lung Cancer

Lung Cancer
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)

Completed

Studying Biomarkers in Patients With Pancreatic Cancer

Pancreatic Cancer

United States
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)

Completed

Erlotinib and Bevacizumab in Treating Patients With Stage IV Melanoma

Melanoma

United States
National Medical Research Center for Therapy and...

Active, not recruiting

Investigation of Specific Biomarkers in Patients With Atrial Fibrillation Who Undergo Interventional Treatment

Atrial Fibrillation

Russian Federation
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

White Button Mushroom Extract in Treating Patients With Recurrent Prostate Cancer After Local Therapy

Prostate Cancer

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Biomarker Expression in Samples From Young Patients With Anaplastic Large Cell Lymphoma

Lymphoma
MejoraVisionMD
Maisonneuve-Rosemont Hospital; Retina and Genomics Institute

Recruiting

Phenotype Correlates Genotype of Inherited Retina Dystrophies, Retinitis Pigmentosa, Con>Rod Dystrophies.

Retinitis Pigmentosa | Usher Syndromes | Cone Dystrophy | Retina; Dystrophy

Mexico
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

Cellular Adoptive Immunotherapy Using Genetically Modified T-Lymphocytes in Treating Patients With Recurrent or Refractory High-Grade Malignant Glioma

Brain and Central Nervous System Tumors
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Studying DNA in Blood and Bone Marrow Samples From Young Patients With Acute Lymphoblastic Leukemia

Leukemia
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)

Terminated

Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial

Cancer
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Biomarkers in Blood and Tissue Samples From Patients With Epstein-Barr Virus-Positive Hodgkin Lymphoma

Lymphoma | Nonneoplastic Condition
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)

Recruiting

Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer

Lung Cancer

United States
Rutgers, The State University of New Jersey
National Cancer Institute (NCI)

Recruiting

Pembrolizumab in Treating Participants With Metastatic, Recurrent or Locally Advanced Cancer and Genomic Instability

BRCA1 Gene Mutation | BRCA2 Gene Mutation | Recurrent Ovarian Carcinoma | Recurrent Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Stage IV Breast Cancer AJCC v6 and v7 | Stage III Breast Cancer AJCC v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC... and other conditions

United States
Barbara Ann Karmanos Cancer Institute
National Cancer Institute (NCI)

Completed

MK-3475 as Maintenance Therapy in Extensive Stage SCLC

Extensive Stage Small Cell Lung Carcinoma

United States
Northwestern University
National Cancer Institute (NCI); Merck Sharp & Dohme LLC

Active, not recruiting

Pembrolizumab and BCG Solution in Treating Patients With Recurrent Non-Muscle-Invasive Bladder Cancer

Recurrent Bladder Carcinoma | Stage I Bladder Cancer | Stage 0a Bladder Urothelial Carcinoma | Stage 0is Bladder Urothelial Carcinoma

United States
Hull University Teaching Hospitals NHS Trust
Barts & The London NHS Trust; Cardiff and Vale University Health Board

Recruiting

Machine Learning in Quantitative Stress Echocardiography (MLQSE)

Cardiovascular Diseases | Ischaemic Heart Disease

United Kingdom
The University of New South Wales

Completed

Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes

Myelodysplastic Syndromes | Leukemia

United Kingdom
University of California, San Francisco

Recruiting

Expanding Fertility Care to Poor and Low Resourced Settings Study (EXPLORE)

Healthy | Fertility Disorders | Male Infertility | Infertility, Male

United States
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Study of Tumor and Blood Samples From Postmenopausal Women With Primary Breast Cancer Enrolled on Clinical Trial CAN-NCIC-MA27

Breast Cancer
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Withdrawn

Studying Tumor Tissue Samples From Patients Who Have Undergone Surgery for Localized Kidney Cancer

Kidney Cancer
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

Studying Blood and Tumor Tissue Samples in Women With Invasive Breast Cancer, Ductal or Lobular Carcinoma in Situ, or Benign Breast Disease

Breast Cancer

United States
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Genetic Markers in Patients With Colorectal Cancer

Colorectal Cancer

United States
Mayo Clinic
National Cancer Institute (NCI)

Completed

Imprime PGG, Alemtuzumab, and Rituximab in Treating Patients With High Risk Chronic Lymphocytic Leukemia

B-cell Chronic Lymphocytic Leukemia | Refractory Chronic Lymphocytic Leukemia | Stage 0 Chronic Lymphocytic Leukemia | Stage I Chronic Lymphocytic Leukemia | Stage II Chronic Lymphocytic Leukemia

United States
National Human Genome Research Institute (NHGRI)
National Cancer Institute (NCI)

Completed

Study of the Results of Education and Counseling for Persons Undergoing Genetic Testing for Hereditary Nonpolyposis Colon Cancer

Colorectal Cancer

United States
Rockefeller University
National Cancer Institute (NCI)

Completed

Effect of Folate on DNA in Colon Tissue and Blood Samples From Patients at Increased Risk of Developing Colorectal Neoplasia

Colorectal Cancer
University of Jordan

Suspended

Evaluation of Shade Matching Capacity of a Contemporary Composite Dental Material

Dental Restoration

Jordan
Cancer Trials Ireland

Completed

Nilotinib in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia

Leukemia

United States, Ireland, Israel, Germany
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Blood and Tumor Tissue Samples From Young Patients With Acute Myeloid Leukemia

Leukemia
University Hospital, Rouen

Completed

Balance Control During Gait (FREINAGE3D)

Healthy

France
Southwest Oncology Group
National Cancer Institute (NCI)

Completed

S0424 - Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer

Lung Cancer

United States
University Hospital Ostrava

Completed

Markers of Tissue Injury and Rhabdomyolysis in Patients With Major Trauma

Rhabdomyolysis | Tissue Injury | Major Trauma

Czechia
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Studying Biomarker Expression in Samples From Patients With Down Syndrome and Acute Myeloid Leukemia or Other Transient Myeloproliferative Disorder

Leukemia
Vanderbilt University
National Cancer Institute (NCI)

Terminated

Presence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell Transplant

Lymphoma | Myelodysplastic Syndromes | Leukemia | Testicular Germ Cell Tumor | Chronic Myeloproliferative Disorders | Cancer Survivor | Neuroblastoma | Multiple Myeloma and Plasma Cell Neoplasm | Myelodysplastic/Myeloproliferative Neoplasms

United States
Rutgers, The State University of New Jersey
National Cancer Institute (NCI); Rutgers Cancer Institute of New Jersey

Completed

Cetuximab Before Surgery in Treating Patients With Aggressive Locally Advanced Skin Cancer

Squamous Cell Carcinoma of the Skin | Recurrent Skin Cancer

United States
NSABP Foundation Inc
National Cancer Institute (NCI)

Unknown

Cancer Stem Cell Biomarkers as a Predictor of Response to Trastuzumab in Samples From Patients With Breast Cancer Previously Treated in the NSABP-B-31 Trial

Breast Cancer
Mayo Clinic
National Cancer Institute (NCI)

Completed

Monoclonal Antibody Therapy in Treating Patients With Stage IV Melanoma

Melanoma (Skin)

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

Anti-IMP3 Autoantibody and MicroRNA Signature Blood Tests in Finding Metastasis in Patients With Localized or Metastatic Kidney Cancer

Kidney Cancer

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Studying Gene Expression in Samples From Younger Patients With Neuroblastoma

Neuroblastoma | Neoplastic Syndrome
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Genetic Test To Identify Previously Undetectable Minimal Residual Disease in Cell Samples From Younger Patients With Acute Lymphoblastic Leukemia

Leukemia
Assistance Publique - Hôpitaux de Paris

Recruiting

Colorimetric, Ultra-structural and Elemental Comparison of Dental Enamel Defects (COLOEMAIL)

Hypomineralization Molar Incisor | Amelogenesis Imperfecta | Dental Fluoroses

France
Jonsson Comprehensive Cancer Center
Merck Sharp & Dohme LLC

Completed

Pembrolizumab in Treating Patients With EGFR Mutant, Tyrosine Kinase Inhibitor Naive Advanced Non-Small Cell Lung Cancer

Stage IIIA Non-Small Cell Lung Cancer | Stage IIIB Non-Small Cell Lung Cancer | Stage IV Non-Small Cell Lung Cancer

United States
University of Sheffield

Unknown

Genes That Affect Disease Progression in Women With Newly Diagnosed or Metastatic Breast Cancer

Breast Cancer

United Kingdom
Cynthia Owusu, MD
National Cancer Institute (NCI)

Completed

Trastuzumab in Treating Older Women With Early-Stage Breast Cancer

Breast Cancer

United States
National Cancer Institute (NCI)

Terminated

Trastuzumab in Treating Patients With Locally Advanced or Metastatic Gallbladder Cancer or Bile Duct Cancer That Cannot Be Removed by Surgery

Malignant Neoplasm | Recurrent Extrahepatic Bile Duct Cancer | Recurrent Gallbladder Cancer | Unresectable Extrahepatic Bile Duct Cancer | Unresectable Gallbladder Cancer | Adenocarcinoma of the Gallbladder | Adenocarcinoma of the Extrahepatic Bile Duct

United States
National Cancer Institute (NCI)

Completed

Trastuzumab in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer That Overexpresses HER2

Stage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer

United States
IRCCS Policlinico S. Donato

Recruiting

miRNAs in Critical Limb Ischemia (miRNACLI) (miRNACLI)

Critical Limb Ischemia

Italy
University of Liege

Recruiting

Gait Analysis of Hemiparetics Adults Patients With Quadripod Cane and Rolling Cane

Stroke | Hemiplegic Gait

Belgium

Search clinical trials for: Immunological analysis:

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Nigeria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations